Schizoaffective Disorder

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Genetic Study of Schizophrenia

Database Registry for Neural Network Biomarkers in Psychosis

Accelerated TMS in Psychosis

Luteolin for the Treatment of People With Schizophrenia

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Enhancing Veteran-Clinical Collaboration in VA PRRCs

Cognitive Strategies in Early Psychosis 2

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

Shared Decision Making for Antipsychotic Medications

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

Early Psychosis Intervention - Spreading Evidence-based Treatment

Cerebellar Modulation of Cognition in Psychosis

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services